Quest Laboratories Limited (NSE:QUESTLAB)

India flag India · Delayed Price · Currency is INR
145.35
+6.90 (4.98%)
Apr 29, 2026, 3:14 PM IST
30.48%
Market Cap 2.38B
Revenue (ttm) 1.26B
Net Income (ttm) 213.89M
Shares Out 16.39M
EPS (ttm) 9.92
PE Ratio 14.66
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 147,600
Average Volume 67,680
Open 145.35
Previous Close 138.45
Day's Range 145.35 - 145.35
52-Week Range 75.15 - 145.35
Beta n/a
RSI 72.61
Earnings Date May 26, 2026

About Quest Laboratories

Quest Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. It provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. The company also engages in contract manufa... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1994
Employees 50
Stock Exchange National Stock Exchange of India
Ticker Symbol QUESTLAB
Full Company Profile

Financial Performance

In fiscal year 2025, Quest Laboratories's revenue was 1.04 billion, an increase of 25.92% compared to the previous year's 825.63 million. Earnings were 135.66 million, an increase of 34.40%.

Financial Statements

News

There is no news available yet.